This article covers:
• Leadership change at Apyx Medical
• Impact of new chairman on innovation and growth
• Andrew Makrides’ legacy and contributions
• Strategic vision under Stavros Vizirgianakis
Board Leadership Transition
In a significant move that marks the beginning of a new chapter for Apyx Medical Corporation, the company has announced a pivotal transition in its board leadership. Stavros Vizirgianakis, a figure well-known in the medical device industry, has been appointed to succeed Andrew Makrides as Chairman of the Board of Directors. This transition comes as Makrides, revered for his more than 40 years of devoted service, retires. Apyx Medical, based in Clearwater, Florida, is recognized for its innovative helium plasma and radiofrequency technology that it markets and sells. This leadership change is poised to drive the company into its next phase of growth and innovation.
Legacy of Innovation
Andrew Makrides leaves behind a substantial legacy of innovation and leadership. Under his guidance, Apyx Medical not only flourished but also cemented its status as a leader in the medical device sector. His retirement marks the end of an era and the beginning of a new one under the stewardship of Stavros Vizirgianakis. Vizirgianakis, with his significant experience in the industry, including his former role as the CEO of Misonix, Inc., which he led to acquisition by Bioventus Inc. in 2021, is expected to bring a fresh perspective to Apyx Medical. His track record of leading companies through periods of growth and innovation makes him an excellent successor to carry forward Makrides’ legacy.
Strategic Vision
The new chairman, Stavros Vizirgianakis, takes the helm with a clear vision for Apyx Medical’s future. His prior experience, particularly at Misonix, Inc., where he demonstrated his capability to steer a company through growth phases and acquisitions, suggests that Apyx Medical is poised for an exciting period of innovation and expansion. Vizirgianakis’ appointment is not just a change in personnel but a signal of Apyx Medical’s commitment to advancing its technology and expanding its market presence. The medical device industry is highly competitive and ever-evolving, and under Vizirgianakis’ leadership, Apyx Medical is expected to continue to innovate and adapt, ensuring its technology remains at the forefront of the sector.
Apyx Medical’s leadership transition is a significant event not only for the company but also for the broader medical device industry. It underscores the importance of innovative leadership in sustaining growth and competitiveness. As Apyx Medical embarks on this new chapter, the industry will be watching closely to see how Vizirgianakis’ strategic vision unfolds and how the company continues to innovate and grow under his guidance. The transition from Makrides to Vizirgianakis is more than a change of guard; it is a testament to the enduring legacy of innovation at Apyx Medical and a look forward to the future possibilities that lie ahead under new leadership.
